• Indications
  • Open Access TIMES Journals
Login Register
Login Register
Indications
  • Oncology · Hematology
  • Spine Surgery
  • Cardiovascular
  • Diabetes + Endocrinology
  • Pneumology
  • Ophthalmology
  • Gynecology · Urology
  • Dermatology · Immunology · Rheumatology
  • Neurology · Psychiatry
  • Gastroenterology
  • Infectiology · Anesthesiology · Pain
  • Primary Care
Open Access TIMES Journals
  • Oncology · Hematology
  • Spine Surgery
  • Cardiovascular
  • Diabetes + Endocrinology
  • Pneumology
  • Ophthalmology
  • Gynecology · Urology
  • Dermatology · Immunology · Rheumatology
  • Neurology · Psychiatry
  • Gastroenterology
  • Infectiology · Anesthesiology · Pain
  • Primary Care
Pneumology

Pneumology

Case Reports
Expert Opinions
Congress News
Webinars
E-Learning
Faculty
Homepage >
Pneumology >
Articles

Updates in Lung Cancer Screening: A Decade of Evidence

Lung Cancer
Share:
Do you want to read an article? Please log in or register.
Register for Free
Remember me
Forgot password? Click here

Related content

RECOMMENDED
Lung CancerFurther Publications
Physical activity and lung cancer screening (PALS): feasibility randomised controlled trial of exercise and physical activity in lung cancer screening
★ 2 Recommended by Dr Martin Frey, Faculty Member
★ 1 Recommended by Dr Marcus Hesse, Faculty Member
Respir Res
Bonney A, Granger CL, Steinfort D, Patrick C, Marshall HM, Fong KM, Manser R
doi: 10.1186/s12931-025-03158-0
RECOMMENDED
Lung Cancer
Structured narrative review on lung cancer screening: current evidence, clinical practice implications and implementation insights from a multidisciplinary task force and patient representatives
★ 2 Recommended by Dr Martin Frey, Faculty Member
★ 3 Recommended by Dr Marcus Hesse, Faculty Member
Eur Respir Rev
Hardavella G, Tavernaraki K, Lioumpas D, Boutsikou E, Karetsi E, Keramida E, Letsos A, Livanios K, Michailidou Ι, Benakis S, Pandi A, Papastavrou L, Stefanidis K, Zervas E, Agapitou T, Andritsou M, Anevlavis S, Apollonatos G, Apostolidou K, Bakiri K, Barmparessou Z, Bellou E, Bisirtzoglou D, Dagdilelis L, Fili E, Foroulis C, Gaitanakis S, Gkriniouk C, Kapetanakis G, Karagiannis K, Karampinis I, Kokkotou E, Kote A, Kostoulas A, Lambaki S, Magouliotis D, Mani M, Metaxas G, Miziou A, Mproupi K, Mytilinaiou S, Potaris K, Samitas K, Skouras V, Spyratos D, Stathoulopoulos A, Stasinopoulou M, Stournara L, Theodorakis E, Tsagaropoulos S, Vittorakis S, Zisis C, Zois P, Gkiozos I
doi: 10.1183/16000617.0249-2024
Lung Cancer
Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)
Lung Cancer
Phillips WJ, Zhan LJ, Chowdhury D, Gill J, Sun A, Rittberg R, Cohen V, Gibson AJW, Yan M, Liwski D, Surapaneni S, D'Amours MF, Yu FPS, Kim Y, Qadeer RA, Dawe DE, Agulnik J, Navani V, Fung AS, Snow S, Kuruvilla S, Ho C, Lok BH, Liu G, Wheatley-Price P, Moore S
doi: 10.1016/j.lungcan.2025.108840
Lung Cancer
Lung Cancer Screening Adherence in Centralized versus Decentralized Screening Programs A Meta-Analysis of U.S. Cohort Studies Among Individuals with Negative Baseline Results
Chest
Ezenwankwo E, Jones C, Nguyen DT, Eberth JM
doi: 10.1016/j.chest.2025.04.033
RECOMMENDED
Lung Cancer
Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group
★ 2 Recommended by Dr Martin Frey, Faculty Member
★ 2 Recommended by Dr Marcus Hesse, Faculty Member
Lung Cancer
Xenophontos E, Giaj Levra N, Durieux V, van Geffen WH, Grisay G, De la Pinta Alonso C, Arasanz H, Prisciandaro E, Ferrara R, Derks J, Von der Thusen J, Dickhoff C, Brandão M, Faivre-Finn C, Edwards J, Ruysscher D, Remon J, Dingemans AC, Berghmans T
doi: 10.1016/j.lungcan.2025.108671
Lung Cancer
Validation of the cancer-specific utility measure EORTC QLU-C10D using evidence from four lung cancer trials covering six country value sets
Sci Rep
Seyringer S, Pilz MJ, Al-Naesan I, King MT, Bottomley A, Norman R, Schlosser L, Hell T, Gamper EM, EORTC Quality of Life Group
doi: 10.1038/s41598-024-83861-y
COMMENTED
Lung Cancer
Effectiveness of NELSON versus PLCOm2012 lung cancer screening eligibility criteria in Germany (HANSE): a prospective cohort study
★ 3 Recommended by Dr Martin Frey, Faculty Member
★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member
Lancet Oncol
Vogel-Claussen J, Bollmann BA, May K, Stiebeler S, Dettmer S, Faron A, Kuhlmann A, Schmid-Bindert G, Kaaks R, Barkhausen J, Bohnet S, Reck M, HANSE investigators
doi: 10.1016/S1470-2045(25)00490-5
Lung Cancer
Osimertinib as First-Line Treatment for Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer in a Real-World Setting: Updated Overall Survival Data (OSI-FACT-OS)
Clin Lung Cancer
Sakata Y, Saito G, Sakata S, Yamaguchi T, Tamiya M, Suzuki H, Shibaki R, Okada A, Yokoyama T, Matsumoto H, Otsuki T, Sato Y, Uchida J, Tsukita Y, Inaba M, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Morinaga J, Sakagami T
doi: 10.1016/j.cllc.2025.05.015
Lung Cancer
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trials
Nat Commun
Welz M, van der Aalst CM, Alfons A, Naghi AA, Heuvelmans MA, Groen HJM, de Jong PA, Aerts J, Oudkerk M, de Koning HJ, Ten Haaf K, NELSON trial consortium
doi: 10.1038/s41467-025-63471-6
  • Contact us
  • About us
  • Privacy Policy & Disclaimer
  • Online Media 2026 Data
  • Imprint
healthbook is a registered trademark. Copyright © 2026 healthbook